Global Innovation – Lessons Learned from the Novo Nordisk Case

Ruxandra Popovici and Nina Birkmose

European Journal of Interdisciplinary Studies, 2011, issue 01

Abstract: This paper looks at the possibilities of Western multinationals to efficiently and effectively relocate research and development to emerging markets. In order to exemplify the findings, we will use the case of Danish pharmaceutical company Novo Nordisk and their approach to the Chinese market. Thus, the research question of this paper is: Which lessons are to be learned from the case of Novo Nordisk in China?

Keywords: foreign market entry; global strategy; offshoring; R&D; pharmaceutics (search for similar items in EconPapers)
JEL-codes: F21 F23 (search for similar items in EconPapers)
Date: 2011
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://ejist.ro/files/pdf/339.pdf (application/pdf)
https://ejist.ro/abstract/339/Global-Innovation-Le ... vo-Nordisk-Case.html (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:jis:ejistu:y:2011:i:01:id:339

Access Statistics for this article

More articles in European Journal of Interdisciplinary Studies from Bucharest Economic Academy Contact information at EDIRC.
Bibliographic data for series maintained by Alina Popescu ().